
APDN Strategy to Address Omicron SARS-CoV-2 Variant
November 29th, 2021
APDN Strategy to Address Omicron SARS-CoV-2 Variant
November 29th, 2021
APDN Submits FDA EUA Request for Linea™ SARS-CoV-2 Mutation Panel
October 25th, 2021
APDN Implements safeCircle™ COVID Testing Program at Sarah Lawrence
October 12th, 2021
Applied DNA Awarded SCC COVID-19 Testing Contract
September 2nd, 2021
Applied DNA Awarded CUNY COVID-19 Testing Contract
August 3rd, 2021
APDN: Clarification on Newly Authorized Asymptomatic Serial Screening
May 13th, 2021
FDA Grants EUA to Applied DNA Linea™ COVID-19 Assay Kit
May 12th, 2021
APDN Receives CLIA Certification, Enabling High Throughput COVID-19 Testing
May 11th, 2021
APDN Secures Amendment to MSA and 4th Blanket Purchase Order
April 26th, 2021